Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Dawn Christine Maroney sold 30,000 shares of the firm's stock in a transaction on Friday, November 15th. The stock was sold at an average price of $11.35, for a total value of $340,500.00. Following the sale, the insider now directly owns 1,696,097 shares of the company's stock, valued at approximately $19,250,700.95. This trade represents a 1.74 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, October 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $10.77, for a total value of $323,100.00.
• On Thursday, August 22nd, Dawn Christine Maroney sold 7,074 shares of Alignment Healthcare stock. The stock was sold at an average price of $9.02, for a total value of $63,807.48.

Alignment Healthcare Stock Performance

ALHC stock traded down $1.35 during trading on Friday, hitting $11.49. The company had a trading volume of 15,157,138 shares, compared to its average volume of 1,107,887. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a 50-day moving average price of $11.55 and a 200-day moving average price of $9.31. Alignment Healthcare, Inc. has a 1-year low of $4.46 and a 1-year high of $14.25. The firm has a market cap of $2.20 billion, a PE ratio of -14.92 and a beta of 1.45.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $692.43 million for the quarter, compared to analysts' expectations of $662.11 million. During the same quarter in the previous year, the firm posted ($0.19) EPS. The firm's quarterly revenue was up 51.6% on a year-over-year basis. On average, analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. UBS Group raised their price target on Alignment Healthcare from $9.00 to $12.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 30th. Piper Sandler reiterated an "overweight" rating and issued a $10.00 target price (up from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. KeyCorp began coverage on Alignment Healthcare in a report on Friday, October 11th. They issued a "sector weight" rating for the company. Robert W. Baird lifted their target price on Alignment Healthcare from $10.00 to $11.00 and gave the company an "outperform" rating in a report on Wednesday, August 14th. Finally, Stifel Nicolaus lifted their target price on Alignment Healthcare from $9.00 to $12.00 and gave the company a "buy" rating in a report on Friday, July 26th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $10.33.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Jacobs Levy Equity Management Inc. purchased a new stake in shares of Alignment Healthcare during the 1st quarter worth approximately $918,000. Vanguard Group Inc. boosted its stake in shares of Alignment Healthcare by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company's stock worth $45,828,000 after acquiring an additional 93,262 shares in the last quarter. Deerfield Management Company L.P. Series C boosted its stake in shares of Alignment Healthcare by 31.8% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company's stock worth $85,250,000 after acquiring an additional 2,630,788 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Alignment Healthcare by 27.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 382,462 shares of the company's stock worth $2,991,000 after acquiring an additional 82,559 shares in the last quarter. Finally, Hood River Capital Management LLC boosted its stake in shares of Alignment Healthcare by 6.4% during the 2nd quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company's stock worth $24,294,000 after acquiring an additional 185,854 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.